Alnylam Pharma (ALNY) Misses Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts ALNY Hot Sheet
Price: $247.31 -1.72%
Revenue Growth %: +15.3%
Financial Fact:
Research and development: 83.17M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +15.3%
Financial Fact:
Research and development: 83.17M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Alnylam Pharma (NASDAQ: ALNY) reported Q2 EPS of ($0.85), $0.10 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $8.69 million versus the consensus estimate of $12.64 million.
For earnings history and earnings-related data on Alnylam Pharma (ALNY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- Worthington Industries (WOR) Tops Q1 EPS by 7c
- General Mills (GIS) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
